Pramlintide as adjunctive treatment to insulin in type 2 diabetes resulted in improved glycemic control and concomitant weight loss

被引：0

|

作者：

Maggs, DG

Burrell, TA

Fineman, MS

Kolterman, OG

机构：

来源：

DIABETES | 2001年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A124 / A125

页数：2

相关论文

共 50 条

[1] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin
Riddle, Matthew
Frias, Juan
Zhang, Bei
Maier, Holly
Brown, Carl
Lutz, Karen
Kolterman, Orville
DIABETES CARE, 2007, 30 (11) : 2794 - 2799
[2] Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 2 diabetes during treatment for 52 weeks
Fineman, M
Gottlieb, A
Skare, S
Kolterman, O
DIABETES, 2000, 49 : A106 - A106
[3] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
Riddle, Matthew
Zhang, Bei
Maier, Holly
Wilhelm, Ken
Kolterman, Orville
DIABETES, 2008, 57 : A156 - A156
[4] Pramlintide treatment for 52 weeks improved glycemic and weight control in people with type 1 diabetes
Gottlieb, A
Velte, M
Fineman, M
Kolterman, O
DIABETOLOGIA, 2000, 43 : A47 - A47
[5] Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 1 diabetes during treatment for 52 weeks
Gottlieb, A
Velte, M
Fineman, M
Kolterman, O
DIABETES, 2000, 49 : A109 - A109
[6] Pramlintide, as an adjunct to basal insulin, reduced C-reactive protein, improved glycemic control, and led to weight loss in patients with type 2 diabetes
Lush, Cameron
Frias, Juan
Zhang, Bei
Maier, Holly
Kolterman, Orville
DIABETES, 2007, 56 : A144 - A144
[7] Pramlintide improved glycemic control and reduced body weight in patients with type 2 diabetes treated with basal insulin (without mealtime insulin) and a thiazolidinedione
Lorenzi, Gayle
Frias, Juan
Lutz, Karen
Kesty, Nicole
Zhang, Bei
Kolterman, Orville
DIABETES, 2007, 56 : A147 - A147
[8] Adjunctive therapy with pramlintide in insulin-treated patients with type 2 diabetes improved glycemic control and cardiometabolic risk factors in routine clinical practice
Bhushan, Rajat
Elkind-Hirsch, Karen E.
Bhushan, Madhu V.
Butler, William J.
Hirsch, David E.
DIABETES, 2007, 56 : A557 - A557
[9] Adjunctive therapy with pramlintide lowers A1c without concomitant weight gain in patients with type 2 diabetes approaching ADA glycemic targets
Weyer, C
Fineman, M
Burrell, T
Strobel, S
Shen, L
Kolterman, O
DIABETES, 2003, 52 : A138 - A138
[10] Pramlintide improved glycemic control without increased risk of hypoglycemia in patients with type 2 diabetes using basal insulin
Lutz, Karen
Maier, Holly
Zhang, Bei
Frias, Juan
DIABETES, 2007, 56 : A143 - A143

← 1 2 3 4 5 →